<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Rees Scientific: 2026 Strategic Growth and Target Plan</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/Chart.js/3.9.1/chart.min.js"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800;900&display=swap" rel="stylesheet">
    <script src="https://unpkg.com/lucide@latest"></script> 
    <style>
        /* BASE STYLES */
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        :root {
            --color-primary: #4F46E5; /* Indigo */
            --color-primary-dark: #4338CA;
            --color-primary-light: #6366F1;
            --color-secondary: #10B981; /* Emerald */
            --color-secondary-dark: #059669;
            --color-text-dark: #1F2937;
            --color-text-light: #4B5563;
        }

        body {
            font-family: 'Inter', sans-serif;
            background-color: #F9FAFB;
            color: var(--color-text-dark);
        }

        .container-xl {
            max-width: 1280px;
            margin: 0 auto;
            padding: 2rem 1rem;
        }

        .card {
            background-color: #FFFFFF;
            border-radius: 1.5rem;
            box-shadow: 0 20px 25px -5px rgba(0, 0, 0, 0.1), 0 8px 10px -6px rgba(0, 0, 0, 0.1);
            padding: 2rem;
            border: 1px solid #E5E7EB;
        }
        
        .card-highlight {
            background-color: #F0F9FF; /* Light Blue */
            border: 2px solid #3B82F6; /* Blue 500 */
        }

        .gradient-text {
            background-image: linear-gradient(to right, var(--color-primary), var(--color-primary-light));
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
        }
        
        .pill-tag {
            display: inline-flex;
            align-items: center;
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 600;
            color: white;
        }
        
        /* 5-TIER MARKET SEGMENTATION COLORS */
        .badge-a { background-color: #DBEAFE; color: #1E40AF; border: 1px solid #93C5FD; } /* Blue */
        .badge-b { background-color: #D1FAE5; color: #047857; border: 1px solid #6EE7B7; } /* Emerald */
        .badge-c { background-color: #F3E8FF; color: #7E22CE; border: 1px solid #D8B4FE; } /* Purple */
        .badge-d { background-color: #FFEDD5; color: #C2410C; border: 1px solid #FDBA74; } /* Orange */
        .badge-e { background-color: #F1F5F9; color: #475569; border: 1px solid #CBD5E1; } /* Slate */
        
        .segment-badge {
            display: inline-block;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.7rem;
            font-weight: 800;
            text-transform: uppercase;
            margin-left: 0.5rem;
            letter-spacing: 0.025em;
        }

        .lhf-item {
            position: relative;
            padding: 1rem;
            border-radius: 0.5rem;
            border-left: 5px solid var(--color-secondary);
            background-color: #F0FDF4;
            margin-bottom: 0.5rem;
        }
        
        /* Social Proof Badges */
        .badge-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(100px, 1fr));
            gap: 1rem;
            margin-top: 1.5rem;
        }
        .proof-badge {
            display: flex;
            flex-direction: column;
            align-items: center;
            justify-content: center;
            padding: 1rem;
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            border-radius: 0.75rem;
            text-align: center;
            font-weight: 700;
            color: #475569;
            transition: all 0.2s;
        }
        .proof-badge:hover {
            border-color: #4F46E5;
            color: #4F46E5;
            background: white;
            box-shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1);
        }
        
        .trend-clip {
            font-style: italic;
            font-size: 0.85rem;
            color: #4B5563;
            margin-top: 0.25rem;
            border-left: 3px solid #93C5FD;
            padding-left: 0.75rem;
            margin-left: 0.25rem;
            line-height: 1.4;
        }
    </style>
</head>
<body>
    <div class="container-xl">

        <!-- HEADER -->
        <header class="text-center mb-12">
            <h1 class="text-5xl font-extrabold mb-3">
                <span class="gradient-text">Rees Scientific: 2026 Strategic Growth Plan</span>
            </h1>
            <p class="text-xl text-gray-500 font-medium">Trend-Driven Execution: The Path to <strong>$65 Million</strong></p>
        </header>

        <!-- 1. FINANCIAL OBJECTIVE -->
        <div class="card mb-12">
            <h2 class="text-3xl font-extrabold mb-6 border-b pb-3 text-gray-700">1. Financial Objective</h2>
            <p class="text-lg mb-8 text-gray-600">
                The core financial objective for the 2026 fiscal year is to achieve <strong>$5M growth</strong>, primarily targeting <strong>Segment A (Pharma Mfg)</strong> and <strong>Segment C (High-Reg Healthcare)</strong> opportunities.
            </p>
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 text-center">
                <div class="p-6 bg-gray-50 rounded-xl shadow-inner">
                    <p class="text-4xl font-extrabold text-gray-800">$60M</p>
                    <p class="text-sm font-semibold uppercase tracking-wider text-gray-500 mt-1">2025 Baseline</p>
                </div>
                <div class="p-6 bg-indigo-50 rounded-xl shadow-lg border-2 border-indigo-200">
                    <p class="text-5xl font-black text-indigo-600">+$5M</p>
                    <p class="text-lg font-extrabold uppercase tracking-widest text-indigo-700 mt-2">Targeted Increase</p>
                </div>
                <div class="p-6 bg-green-50 rounded-xl shadow-inner">
                    <p class="text-4xl font-extrabold text-green-700">$65M</p>
                    <p class="text-sm font-semibold uppercase tracking-wider text-gray-500 mt-1">2026 Goal</p>
                </div>
            </div>
        </div>

        <!-- 2. MARKET SEGMENTATION INDEX (Moved Up for Strategic Context) -->
        <div class="card mb-12">
            <h2 class="text-3xl font-extrabold mb-6 border-b pb-3 text-gray-700">2. Strategic Context: Market Segmentation Index</h2>
            <p class="mb-6 text-gray-600">Our strategy categorizes targets into 5 distinct regulatory tiers. This framework dictates the specific compliance solution (Validation vs. Monitoring) and pricing model required for each prospect.</p>
            
            <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6">
                <!-- A -->
                <div class="p-5 bg-blue-50 rounded-xl border-l-8 border-blue-700">
                    <p class="text-2xl font-black text-blue-800 mb-1">Segment A</p>
                    <p class="font-bold text-blue-700 mb-2">Pharma & Biotech Manufacturing</p>
                    <p class="text-sm text-blue-600">Focus: CGT, Biologics production. Drivers: FDA, cGMP.</p>
                </div>
                <!-- B -->
                <div class="p-5 bg-emerald-50 rounded-xl border-l-8 border-emerald-600">
                    <p class="text-2xl font-black text-emerald-800 mb-1">Segment B</p>
                    <p class="font-bold text-emerald-700 mb-2">Pharma Labs, CROs, Reference Labs</p>
                    <p class="text-sm text-emerald-600">Focus: R&D Testing. Drivers: GLP, Audits.</p>
                </div>
                <!-- C -->
                <div class="p-5 bg-purple-50 rounded-xl border-l-8 border-purple-600">
                    <p class="text-2xl font-black text-purple-800 mb-1">Segment C</p>
                    <p class="font-bold text-purple-700 mb-2">Very Highly Regulated Healthcare</p>
                    <p class="text-sm text-purple-600">Focus: LN2, Specialty Pharma, Cleanrooms. Drivers: USP &lt;797&gt;/&lt;800&gt;.</p>
                </div>
                <!-- D -->
                <div class="p-5 bg-orange-50 rounded-xl border-l-8 border-orange-600">
                    <p class="text-2xl font-black text-orange-800 mb-1">Segment D</p>
                    <p class="font-bold text-orange-700 mb-2">Highly Regulated Healthcare</p>
                    <p class="text-sm text-orange-600">Focus: Tissue & Blood Banks. Drivers: AABB, AATB.</p>
                </div>
                <!-- E -->
                <div class="p-5 bg-slate-100 rounded-xl border-l-8 border-slate-500">
                    <p class="text-2xl font-black text-slate-700 mb-1">Segment E</p>
                    <p class="font-bold text-slate-600 mb-2">Low Regulated</p>
                    <p class="text-sm text-slate-500">Focus: Pathology Labs, Vaccine Storage, Patient Monitoring.</p>
                </div>
            </div>
        </div>

        <!-- 3. STRATEGIC GROWTH PILLARS -->
        <div class="card mb-12">
            <h2 class="text-3xl font-extrabold mb-8 border-b pb-3 text-gray-700">3. Strategic Pillars: Capitalizing on Trends</h2>
            <p class="text-lg mb-8 text-gray-600">The growth strategy is driven by three primary mandates aligned with the highest compliance segments <strong>(A, B, C, D)</strong>.</p>

            <div class="grid grid-cols-1 lg:grid-cols-3 gap-8">
                <!-- Pillar 1 -->
                <div class="p-6 bg-white rounded-xl border border-gray-200 shadow-md hover:shadow-xl transition">
                    <div class="flex items-center mb-4">
                        <span class="p-3 bg-indigo-100 rounded-full text-indigo-600 glow-icon mr-4"><svg data-lucide="microscope" class="w-6 h-6"></svg></span>
                        <h3 class="text-xl font-bold">1. CGT & Pharma Manufacturing</h3>
                    </div>
                    <p class="text-sm text-gray-600 mb-3"><strong>Trend:</strong> Rapid cleanroom construction driven by Cell & Gene Therapy (CGT) investment.</p>
                    <p class="text-sm text-indigo-800 font-bold">Primary Target: Segment A</p>
                </div>
                <!-- Pillar 2 -->
                <div class="p-6 bg-white rounded-xl border border-gray-200 shadow-md hover:shadow-xl transition">
                    <div class="flex items-center mb-4">
                        <span class="p-3 bg-indigo-100 rounded-full text-indigo-600 glow-icon mr-4"><svg data-lucide="cloud" class="w-6 h-6"></svg></span>
                        <h3 class="text-xl font-bold">2. Modernization & Cloud</h3>
                    </div>
                    <p class="text-sm text-gray-600 mb-3"><strong>Trend:</strong> Replacement of legacy/paper systems to meet new data integrity rules (Annex 11 / 21 CFR Part 11).</p>
                    <p class="text-sm text-emerald-700 font-bold">Primary Target: Segment B</p>
                </div>
                <!-- Pillar 3 -->
                <div class="p-6 bg-white rounded-xl border border-gray-200 shadow-md hover:shadow-xl transition">
                    <div class="flex items-center mb-4">
                        <span class="p-3 bg-indigo-100 rounded-full text-indigo-600 glow-icon mr-4"><svg data-lucide="heart-handshake" class="w-6 h-6"></svg></span>
                        <h3 class="text-xl font-bold">3. Healthcare Compliance</h3>
                    </div>
                    <p class="text-sm text-gray-600 mb-3"><strong>Trend:</strong> Mandatory monitoring for compounding pharmacies (C) and tissue storage (D).</p>
                    <p class="text-sm text-purple-700 font-bold">Primary Target: Segment C & D</p>
                </div>
            </div>
        </div>

        <!-- 4. REGIONAL ALLOCATION -->
        <div class="card mb-12">
            <h2 class="text-3xl font-extrabold mb-6 border-b pb-3 text-gray-700">4. Regional Growth Allocation</h2>
            <p class="text-lg mb-8 text-gray-600">The total <strong>$5M growth</strong> is allocated across regions to ensure every territory contributes to the goal through a mix of high-value new logo acquisition and aggressive existing client upsells.</p>

            <div class="overflow-x-auto">
                <table class="min-w-full divide-y divide-gray-200">
                    <thead class="bg-gray-50">
                        <tr>
                            <th class="px-6 py-3 text-left text-xs font-bold text-gray-500 uppercase">Region</th>
                            <th class="px-6 py-3 text-right text-xs font-bold text-gray-500 uppercase">Target Contribution</th>
                            <th class="px-6 py-3 text-right text-xs font-bold text-gray-500 uppercase">Primary Segment Focus</th>
                        </tr>
                    </thead>
                    <tbody class="bg-white divide-y divide-gray-200">
                        <tr>
                            <td class="px-6 py-4 font-medium text-indigo-600">Northeast</td>
                            <td class="px-6 py-4 text-right text-green-700 font-bold">$1.4M (28%)</td>
                            <td class="px-6 py-4 text-right text-gray-600">Segment A (Pharma Mfg)</td>
                        </tr>
                        <tr>
                            <td class="px-6 py-4 font-medium text-indigo-600">West</td>
                            <td class="px-6 py-4 text-right text-green-700 font-bold">$1.0M (20%)</td>
                            <td class="px-6 py-4 text-right text-gray-600">Segment A (Biotech) & B (Labs)</td>
                        </tr>
                        <tr>
                            <td class="px-6 py-4 font-medium text-indigo-600">Southern</td>
                            <td class="px-6 py-4 text-right text-green-700 font-bold">$0.9M (18%)</td>
                            <td class="px-6 py-4 text-right text-gray-600">Segment C (Hospital Compliance)</td>
                        </tr>
                        <tr>
                            <td class="px-6 py-4 font-medium text-indigo-600">SW Central</td>
                            <td class="px-6 py-4 text-right text-green-700 font-bold">$0.7M (14%)</td>
                            <td class="px-6 py-4 text-right text-gray-600">Segment C & B (Academic/Research)</td>
                        </tr>
                        <tr>
                            <td class="px-6 py-4 font-medium text-indigo-600">Europe</td>
                            <td class="px-6 py-4 text-right text-green-700 font-bold">$0.8M (16%)</td>
                            <td class="px-6 py-4 text-right text-gray-600">Segment A (Annex 11 Migration)</td>
                        </tr>
                        <tr>
                            <td class="px-6 py-4 font-medium text-indigo-600">Federal</td>
                            <td class="px-6 py-4 text-right text-green-700 font-bold">$0.2M (4%)</td>
                            <td class="px-6 py-4 text-right text-gray-600">Segment C (Gov Standardization)</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <!-- 5. REGIONAL EXECUTION: TARGET LISTS -->
        <div class="card bg-white mb-12">
            <h2 class="text-3xl font-extrabold mb-4 border-b pb-3 text-gray-700">5. Regional Execution: Trend-Based Targets</h2>
            <p class="text-lg text-gray-600 mb-8">A dual strategy of <strong>New Logo Acquisition</strong> and <strong>Existing Client Expansion</strong>, strictly aligned with the A-E Market Segments.</p>
            
            <!-- KEY LEGEND (MOVED TO TOP FOR CLARITY) -->
            <div class="mb-8 p-4 bg-gray-50 rounded-lg border border-gray-200">
                <h4 class="text-sm font-bold text-gray-700 mb-2 uppercase tracking-wide">Market Segmentation Key</h4>
                <div class="grid grid-cols-2 sm:grid-cols-3 md:grid-cols-5 gap-2">
                    <span class="segment-badge badge-a">A: Pharma Mfg</span>
                    <span class="segment-badge badge-b">B: Labs/CROs</span>
                    <span class="segment-badge badge-c">C: Very High Reg Healthcare</span>
                    <span class="segment-badge badge-d">D: High Reg Healthcare</span>
                    <span class="segment-badge badge-e">E: Low Regulated</span>
                </div>
            </div>

            <!-- REGION 1: NORTHEAST -->
            <div class="mb-10">
                <h3 class="text-2xl font-bold mb-4 text-indigo-700">Northeast Region ($1.4M)</h3>
                <div class="grid grid-cols-1 lg:grid-cols-2 gap-6">
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">New Logo Acquisition (10 Lookalikes)</h4>
                        <ul class="space-y-3 text-sm text-gray-700">
                            <!-- Segment A Targets with Industry Clips -->
                            <li>
                                <strong>Vertex Pharmaceuticals</strong> (MA) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">Targeted due to aggressive investment in CRISPR/gene editing manufacturing capacity (Pillar 1).</p>
                            </li>
                            <li>
                                <strong>Biogen</strong> (MA) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">Biologics expansion and need for Part 11 compliant data management across R&D and pilot plants (Pillar 2).</p>
                            </li>
                            <!-- Mixed Segments -->
                            <li><strong>Charles River Labs</strong> (MA/PA) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>Eurofins Scientific</strong> (PA/NJ) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>Northwell Health</strong> (NY) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Mass General Brigham</strong> (MA) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Children's National Hospital</strong> (DC) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>New York Blood Center</strong> (NY) <span class="segment-badge badge-d">D</span></li>
                            <li><strong>Mount Auburn Hospital</strong> (MA) <span class="segment-badge badge-d">D</span></li>
                            <li><strong>Quest Diagnostics</strong> (NJ/NY) <span class="segment-badge badge-e">E</span></li>
                        </ul>
                    </div>
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">Expansion Targets (LHF)</h4>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Regeneron Pharmaceuticals (NY) <span class="segment-badge badge-a">A</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Enterprise Expansion (Pillar 1).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Dana-Farber Cancer Inst (MA) <span class="segment-badge badge-c">C</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> CGT Validation Services up-sell (Pillar 1).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Moderna (MA/QC) <span class="segment-badge badge-a">A</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Manufacturing capacity expansion (Pillar 1).</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- REGION 4: WEST -->
            <div class="mb-10">
                <h3 class="text-2xl font-bold mb-4 text-indigo-700">West Region ($1.0M)</h3>
                <div class="grid grid-cols-1 lg:grid-cols-2 gap-6">
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">New Logo Acquisition (10 Lookalikes)</h4>
                        <p class="text-xs text-gray-500 mb-2"><strong>Strategic Gap:</strong> Major players missing from current client list.</p>
                        <ul class="space-y-3 text-sm text-gray-700">
                            <!-- Segment A Targets with Industry Clips -->
                            <li>
                                <strong>Genentech (Roche)</strong> (South SF) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">Focus on major new cleanroom validation projects (Pillar 1).</p>
                            </li>
                            <li>
                                <strong>BioMarin Pharmaceutical</strong> (San Rafael) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">Gene therapy production scaling requires end-to-end Part 11 CEMS (Pillar 1).</p>
                            </li>
                            <!-- Mixed Segments -->
                            <li><strong>Stanford Health Care</strong> (Palo Alto) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Neurocrine Biosciences</strong> (San Diego) <span class="segment-badge badge-a">A</span></li>
                            <li><strong>Scripps Health</strong> (San Diego) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Labcorp</strong> (CA/WA Labs) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>Kaiser Permanente</strong> (CA/WA) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Adaptive Biotechnologies</strong> (WA) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>San Diego Blood Bank</strong> (CA) <span class="segment-badge badge-d">D</span></li>
                            <li><strong>Quest Diagnostics</strong> (CA Labs) <span class="segment-badge badge-e">E</span></li>
                        </ul>
                    </div>
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">Expansion Targets (LHF)</h4>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Kite Pharma (Gilead) (CA) <span class="segment-badge badge-a">A</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Validation for new mfg suites (Pillar 1).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Sana Biotechnologies (South SF) <span class="segment-badge badge-b">B</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Cloud Migration & Enterprise expansion (Pillar 2).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">City of Hope (Duarte) <span class="segment-badge badge-c">C</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> USP &lt;800&gt; Pharmacy Compliance upgrade (Pillar 3).</p>
                        </div>
                         <div class="lhf-item">
                            <p class="font-bold text-gray-800">Seattle Genetics (Seagen) (WA) <span class="segment-badge badge-a">A</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Pfizer integration & standardization (Pillar 1).</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- REGION 2: SOUTHERN (FINALIZED) -->
            <div class="mb-10">
                <h3 class="text-2xl font-bold mb-4 text-indigo-700">Southern Region ($0.9M)</h3>
                <div class="grid grid-cols-1 lg:grid-cols-2 gap-6">
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">New Logo Acquisition (10 Lookalikes)</h4>
                        <ul class="space-y-3 text-sm text-gray-700">
                            <!-- Segment A Targets with Industry Clips -->
                            <li>
                                <strong>Fujifilm Diosynth</strong> (NC) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">CDMO expansion requires immediate cGMP-compliant CEMS systems (Pillar 1).</p>
                            </li>
                            <li>
                                <strong>Vetoquinol USA</strong> (FL) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">Animal Health manufacturing sites require FDA data integrity solutions (Pillar 1).</p>
                            </li>
                            <!-- Mixed Segments -->
                            <li><strong>Research Triangle Institute</strong> (NC) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>Texas Biomed Research Institute</strong> (TX) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>Labcorp Drug Development</strong> (NC/FL) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>MD Anderson Cancer Center</strong> (TX) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Baylor Scott & White Health</strong> (TX) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>HCA Healthcare</strong> (TN/FL) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Sanford Health</strong> (TN) <span class="segment-badge badge-d">D</span></li>
                            <li><strong>Novant Health System</strong> (NC) <span class="segment-badge badge-c">C</span></li>
                        </ul>
                    </div>
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">Expansion Targets (LHF)</h4>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Eli Lilly (NC/TX) <span class="segment-badge badge-a">A</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Manufacturing ramp-up support (Pillar 1).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Texas Medical Center <span class="segment-badge badge-c">C</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Cross-sell to new member institutions (Pillar 3).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Vanderbilt University Medical Ctr <span class="segment-badge badge-c">C</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Service contract renewal/upsell (Pillar 3).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Duke University Health (NC) <span class="segment-badge badge-c">C</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Pharmacy/Blood Bank Expansion (Pillar 3).</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- REGION 3: SW CENTRAL (FINALIZED) -->
            <div class="mb-10">
                <h3 class="text-2xl font-bold mb-4 text-indigo-700">SW Central Region ($0.7M)</h3>
                <div class="grid grid-cols-1 lg:grid-cols-2 gap-6">
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">New Logo Acquisition (10 Lookalikes)</h4>
                        <ul class="space-y-3 text-sm text-gray-700">
                            <!-- Segment A Targets with Industry Clips -->
                            <li>
                                <strong>Catalent CDMO</strong> (IN/WI) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">Expanding sterile injectables capacity to meet global GLP-1 demand requires fast validation.</p>
                            </li>
                            <li>
                                <strong>Bayer Animal Health</strong> (KS) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">Animal health manufacturing expansion requires robust Part 11 CEMS solutions.</p>
                            </li>
                            <!-- Mixed Segments -->
                            <li><strong>St. Jude Children's Research Hospital</strong> (TN) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Mayo Clinic</strong> (MN) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Becton Dickinson (BD)</strong> (NE) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>Cardinal Health</strong> (OH) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>Washington University School of Medicine</strong> (MO) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Children's Mercy Kansas City</strong> (MO) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Grifols</strong> (IL Blood Plasma) <span class="segment-badge badge-d">D</span></li>
                            <li><strong>Indiana University Health</strong> (IN) <span class="segment-badge badge-c">C</span></li>
                        </ul>
                    </div>
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">Expansion Targets (LHF)</h4>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Nationwide Children's Hospital (OH) <span class="segment-badge badge-c">C</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Service Bundle Upsell (Pillar 3).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">University of Michigan Health (MI) <span class="segment-badge badge-d">D</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Tissue/Blood Bank AABB compliance (Pillar 3).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">AbbVie (IL) <span class="segment-badge badge-a">A</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Legacy server migration (Pillar 2).</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- REGION 5: EUROPE (FINALIZED) -->
            <div class="mb-10">
                <h3 class="text-2xl font-bold mb-4 text-indigo-700">Europe Region ($0.8M)</h3>
                <div class="grid grid-cols-1 lg:grid-cols-2 gap-6">
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">New Logo Acquisition (10 Lookalikes)</h4>
                        <ul class="space-y-3 text-sm text-gray-700">
                            <!-- Segment A Targets with Industry Clips -->
                            <li>
                                <strong>Bayer Pharmaceuticals</strong> (DE/IE) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">Expanding gene therapy footprint across Europe requires standardized, Annex 11 compliant CEMS.</p>
                            </li>
                            <li>
                                <strong>Novartis</strong> (CH) <span class="segment-badge badge-a">A</span>
                                <p class="trend-clip">Cell therapy expansion requires new cleanroom validation across multiple EU sites.</p>
                            </li>
                            <!-- Mixed Segments -->
                            <li><strong>Sartorius Stedim</strong> (DE/FR) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>Sanofi</strong> (FR) <span class="segment-badge badge-a">A</span></li>
                            <li><strong>Roche</strong> (CH/DE) <span class="segment-badge badge-a">A</span></li>
                            <li><strong>University of Oxford</strong> (UK) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Karolinska Institutet</strong> (SE) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Sandoz</strong> (AT/DE) <span class="segment-badge badge-a">A</span></li>
                            <li><strong>Gilead Sciences</strong> (IE) <span class="segment-badge badge-b">B</span></li>
                            <li><strong>Lonza</strong> (CH) <span class="segment-badge badge-a">A</span></li>
                        </ul>
                    </div>
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">Expansion Targets (LHF)</h4>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">AstraZeneca (UK) <span class="segment-badge badge-a">A</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Annex 11 Cloud Migration (Pillar 2).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Lonza (CH/IE) <span class="segment-badge badge-b">B</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Viral Vector CDMO Expansion (Pillar 1).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Charité - Universitätsmedizin Berlin (DE) <span class="segment-badge badge-c">C</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Cleanroom USP modernization (Pillar 3).</p>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- REGION 6: FEDERAL (FINALIZED) -->
            <div class="mb-10">
                <h3 class="text-2xl font-bold mb-4 text-indigo-700">Federal / National Targets ($0.2M)</h3>
                <div class="grid grid-cols-1 lg:grid-cols-2 gap-6">
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">New Logo Acquisition (10 Lookalikes)</h4>
                        <ul class="space-y-2 text-sm text-gray-700">
                            <li><strong>Walter Reed National Military Medical Center</strong> <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Defense Health Agency (DHA)</strong> <span class="segment-badge badge-d">D</span></li>
                            <li><strong>Veterans Health Administration (VHA)</strong> <span class="segment-badge badge-c">C</span></li>
                            <li><strong>FDA Center for Biologics Evaluation (CBER)</strong> <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Fort Bragg Military Hospital</strong> <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Johns Hopkins Health System</strong> (MD) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>National Institutes of Health (NIH)</strong> (Bethesda) <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Centers for Disease Control (CDC)</strong> <span class="segment-badge badge-c">C</span></li>
                            <li><strong>Naval Medical Research Center (NMRC)</strong> <span class="segment-badge badge-d">D</span></li>
                            <li><strong>Uniformed Services University (USU)</strong> <span class="segment-badge badge-c">C</span></li>
                        </ul>
                    </div>
                    <div>
                        <h4 class="text-lg font-bold mb-3 border-b pb-1 text-gray-800">Expansion Targets (LHF)</h4>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">NIH Modernization (MD) <span class="segment-badge badge-c">C</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> SRLM Lab Wing compliance (Pillar 3).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">American Red Cross (ARC) <span class="segment-badge badge-d">D</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> National Cold Chain Standardization (Pillar 3).</p>
                        </div>
                        <div class="lhf-item">
                            <p class="font-bold text-gray-800">Naval Medical Center (CA/MD) <span class="segment-badge badge-d">D</span></p>
                            <p class="text-xs text-gray-600"><strong>Opportunity:</strong> Blood Bank standardization (Pillar 3).</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- 7. EXECUTION MANDATE -->
        <div class="card bg-indigo-900 text-white">
            <h2 class="text-2xl font-bold mb-4">7. Execution Mandate</h2>
            <ul class="list-disc pl-5 space-y-2 text-gray-100">
                <li><strong>Pipeline Activation:</strong> All "Lookalike" targets in Section 5 have been entered into CRM for immediate Q1 pursuit.</li>
                <li><strong>Segment Discipline:</strong> Every opportunity must be qualified against the A-E criteria to ensure we are selling the right value proposition (e.g., Validation for Segment A, Audit Defense for Segment D).</li>
                <li><strong>Expansion Priority:</strong> Secure the LHF targets by Q2 to build the revenue bridge to $65M.</li>
            </ul>
        </div>

    </div>
    <script>
        lucide.createIcons();
    </script>
</body>
</html>